Genital human papillomavirus infection.

Por Lowy, D R, Kirnbauer, R, Schiller, J T
Publicado em 1994

Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids

Por Handisurya, A, Schellenbacher, C, Haitel, A, Senger, T, Kirnbauer, R
Publicado no Br J Cancer (2016)

The Kühtai data set: 25 years of lysimetric, snow pillow, and meteorological measurements

Por Krajči, P., Kirnbauer, R., Parajka, J., Schöber, J., Blöschl, G.
Publicado no Water Resour Res (2017)

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Por Kirnbauer, R, Booy, F, Cheng, N, Lowy, D R, Schiller, J T
Publicado em 1992

Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses

Por HAINISCH, E. K., BRANDT, S., SHAFTI-KERAMAT, S., VAN DEN HOVEN, R., KIRNBAUER, R.
Publicado em 2011

Interaction of papillomaviruses with the cell surface.

Por Roden, R B, Kirnbauer, R, Jenson, A B, Lowy, D R, Schiller, J T
Publicado em 1994

Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity

Por Schellenbacher, C., Huber, B., Skoll, M., Shafti-Keramat, S., Roden, R.B.S., Kirnbauer, R.
Publicado no Vaccine (2019)

Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy

Por Handisurya, A., Rieger, A., Bankier, A., Koller, A., Salat, A., Stingl, G., Kirnbauer, R.
Publicado em 2007

Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor.

Por Roden, R B, Hubbert, N L, Kirnbauer, R, Breitburd, F, Lowy, D R, Schiller, J T
Publicado em 1995

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.

Por Roden, R B, Hubbert, N L, Kirnbauer, R, Christensen, N D, Lowy, D R, Schiller, J T
Publicado em 1996

Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Por Kirnbauer, R, Taub, J, Greenstone, H, Roden, R, Dürst, M, Gissmann, L, Lowy, D R, Schiller, J T
Publicado em 1993

Rapid progression of an anal Buschke–Löwenstein tumour into a metastasising squamous cell carcinoma in an HIV-infected patient

Por Handisurya, A, Rieger, A, Bago-Horvath, Z, Schellenbacher, C, Bankier, A, Salat, A, Stingl, G, Kirnbauer, R
Publicado em 2009

In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Por Roden, R B, Greenstone, H L, Kirnbauer, R, Booy, F P, Jessie, J, Lowy, D R, Schiller, J T
Publicado em 1996

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

Por Breitburd, F, Kirnbauer, R, Hubbert, N L, Nonnenmacher, B, Trin-Dinh-Desmarquet, C, Orth, G, Schiller, J T, Lowy, D R
Publicado em 1995

Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.

Por Roden, R B, Armstrong, A, Haderer, P, Christensen, N D, Hubbert, N L, Lowy, D R, Schiller, J T, Kirnbauer, R
Publicado em 1997

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

Por Roden, R B, Weissinger, E M, Henderson, D W, Booy, F, Kirnbauer, R, Mushinski, J F, Lowy, D R, Schiller, J T
Publicado em 1994

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study.

Por Lehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Kirnbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J. T., Hakama, M.
Publicado em 1996